Soc. Generale Call 12000 DP4B 21..../ DE000SW9XCY0 /
11/06/2024 9:04:14 | Diferencia-0.140 | Bid12:21:55 | Ask12:21:55 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.560EUR | -20.00% | 0.350 Volumen de oferta: 15,000 |
0.360 Tamaño/ Volumen/ Formato de Ask: 15,000 |
A.P.MOELL.-M.NAM B D... | 12,000.00 - | 21/06/2024 | Call |
GlobeNewswire
12:39
SQUARESPACE ALERT: Is $44 Per Share Too Low for Squarespace (NYSE: SQSP)? BFA Law is Investigating a...
GlobeNewswire
12:36
SPROUT SOCIAL NOTICE: If You Suffered Losses on Your Sprout Social (Nasdaq: SPT) Investment, You are...
GlobeNewswire
12:33
POWERSCHOOL ALERT: Is $22.80 Per Share Too Low for PowerSchool (NYSE: PWSC)? BFA Law is Investigatin...
GlobeNewswire
12:31
UIPATH NOTICE: If You Suffered Losses When UiPath, Inc.’s (NYSE: PATH) Stock Dropped 34%, You are Re...
GlobeNewswire
12:30
Park Hotels & Resorts Announces Second Quarter 2024 Earnings Conference Call on August 1, 2024
GlobeNewswire
12:30
Fastly ALERT: Securities Fraud Lawsuit Could Allow Investors to Recover Losses; Block & Leviton Enco...
GlobeNewswire
12:28
CEREVEL ALERT: Is $45 Per Share Too Low for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Urg...
GlobeNewswire
12:00
Liberty Gold Announces Approval of the Fourth Plan of Operations Amendment, Black Pine Oxide Gold Pr...
GlobeNewswire
12:00
RadNet, Inc. to Present at the Sidoti & Company 2024 Small Cap Conference on Wednesday, June 12th
GlobeNewswire
12:00
SiteMinder and Cloudbeds partner to create new distribution and revenue opportunities for hotels
GlobeNewswire
12:00
Digihost Expands Bitcoin Mining Operations with 11,000 S21s Increasing Hashing Rate to 3.2 EH/s
GlobeNewswire
12:00
Kepler Validates SDA-Compatible Optical Technology For Space Data Relay Constellation
GlobeNewswire
12:00
FreedomPay Launches Industry’s First Independent Payment Processing Referral Advisory for Merchants
GlobeNewswire
12:00
Iveco Group signs a 150 million euro term loan facility with Cassa Depositi e Prestiti to support in...
GlobeNewswire
12:00
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página